drugset / Trial / NCT02446340
Multiple Ascending Dose Safety Study of ShK-186 (Dalazatide) in Healthy Volunteers
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to examine safety outcomes in healthy volunteers after systemic administration of multiple ascending doses of dalazatide.
Timeline
- Start
- 2013-11
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | dalazatide | Protein / enzyme biologic | 5 ug | Subcutaneous |
| Subject | dalazatide | Protein / enzyme biologic | 15 ug | Subcutaneous |
| Subject | dalazatide | Protein / enzyme biologic | 30 ug | Subcutaneous |
| Subject | dalazatide | Protein / enzyme biologic | 60 ug | Subcutaneous |
Indications
No indication recorded.